TherapeuticsMD Inc (TXMD)
1.46
-0.04
(-2.48%)
USD |
NASDAQ |
Nov 14, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 20:00
TherapeuticsMD Enterprise Value: 11.61M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 11.61M |
| November 13, 2024 | 12.03M |
| November 12, 2024 | 12.07M |
| November 11, 2024 | 12.30M |
| November 08, 2024 | 12.30M |
| November 07, 2024 | 12.30M |
| November 06, 2024 | 12.53M |
| November 05, 2024 | 12.53M |
| November 04, 2024 | 12.64M |
| November 01, 2024 | 12.63M |
| October 31, 2024 | 12.64M |
| October 30, 2024 | 12.64M |
| October 29, 2024 | 12.87M |
| October 28, 2024 | 12.82M |
| October 25, 2024 | 13.10M |
| October 24, 2024 | 12.99M |
| October 23, 2024 | 12.93M |
| October 22, 2024 | 12.99M |
| October 21, 2024 | 12.93M |
| October 18, 2024 | 13.22M |
| October 17, 2024 | 12.99M |
| October 16, 2024 | 12.99M |
| October 15, 2024 | 12.38M |
| October 14, 2024 | 12.30M |
| October 11, 2024 | 12.99M |
| Date | Value |
|---|---|
| October 10, 2024 | 12.99M |
| October 09, 2024 | 12.99M |
| October 08, 2024 | 13.45M |
| October 07, 2024 | 13.91M |
| October 04, 2024 | 13.71M |
| October 03, 2024 | 13.22M |
| October 02, 2024 | 13.80M |
| October 01, 2024 | 13.68M |
| September 30, 2024 | 13.91M |
| September 27, 2024 | 13.68M |
| September 26, 2024 | 13.80M |
| September 25, 2024 | 13.22M |
| September 24, 2024 | 14.03M |
| September 23, 2024 | 14.26M |
| September 20, 2024 | 14.49M |
| September 19, 2024 | 14.60M |
| September 18, 2024 | 13.91M |
| September 17, 2024 | 14.60M |
| September 16, 2024 | 14.49M |
| September 13, 2024 | 15.41M |
| September 12, 2024 | 15.41M |
| September 11, 2024 | 15.27M |
| September 10, 2024 | 14.95M |
| September 09, 2024 | 15.41M |
| September 06, 2024 | 14.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.774M
Minimum
Mar 22 2023
994.54M
Maximum
Feb 09 2021
265.69M
Average
229.97M
Median
Feb 11 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.833M |
| Palatin Technologies Inc | 11.39M |
| iBio Inc | 5.346M |
| Theriva Biologics Inc | -13.34M |
| Oragenics Inc | 2.080M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.09M |
| Revenue (Quarterly) | 0.234M |
| Total Expenses (Quarterly) | 1.413M |
| EPS Diluted (Quarterly) | -0.09 |
| Profit Margin (Quarterly) | -465.8% |
| Earnings Yield | -36.30% |
| Normalized Earnings Yield | -22.24 |